Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Cured meat consumption increases risk of readmission in COPD patients

Jordi de Batlle, Michelle Mendez, Isabelle Romieu, Eva Balcells, Marta Benet, David Donaire-Gonzalez, Jaume J. Ferrer, Mauricio Orozco-Levi, Josep M. Antó, Judith Garcia-Aymerich, the PAC-COPD Study Group
European Respiratory Journal 2012 40: 555-560; DOI: 10.1183/09031936.00116911
Jordi de Batlle
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Mendez
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Romieu
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Balcells
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Benet
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Donaire-Gonzalez
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaume J. Ferrer
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauricio Orozco-Levi
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josep M. Antó
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith Garcia-Aymerich
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
For affiliation details and a full list of the PAC-COPD Study Group members see the Acknowledgements section
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Recent studies have shown that a high dietary intake of cured meat increases the risk of chronic obstructive pulmonary disease (COPD) development. However, its potential effects on COPD evolution have not been tested. We aimed to assess the association between dietary intake of cured meat and risk of COPD readmission in COPD patients.

274 COPD patients were recruited during their first COPD admission between 2004 and 2006, provided information on dietary intake of cured meat during the previous 2 yrs, and were followed until December 31, 2007 (median follow-up 2.6 yrs). Associations between cured meat intake and COPD admissions were assessed using parametric regression survival–time models.

Mean±sd age was 68±8 yrs, 93% of patients were male, 42% were current smokers, mean post-bronchodilator forced expiratory volume in 1 s (FEV1) was 53±16% predicted, and median cured meat intake was 23 g·day−1. After adjusting for age, FEV1, and total caloric intake, high cured meat intake (more than median value) increased the risk of COPD readmission (adjusted HR 2.02, 95% CI 1.31–3.12; p=0.001).

High cured meat consumption increases the risk of COPD readmission in COPD patients. The assessment of the effectiveness of healthy diet advice should be considered in the future.

  • Chronic obstructive pulmonary disease
  • follow-up studies
  • hospitalisation
  • meat products
  • public health

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, and is expected to become the fourth leading cause of mortality by 2030 [1]. Although cigarette smoking is the main risk factor for COPD, interest has recently increased in the hypothesis that specific components of diet could play a role in the development of disease [2, 3]. Fruits and vegetables have captured most of the interest, given their antioxidant properties, and more recently several studies have pointed out that cured meat could have deleterious effects [4–6]. Two US prospective cohorts have shown an increased risk of COPD incidence among subjects reporting higher cured meat intake [5, 6]. This effect has been attributed to the fact that nitrites, which are added as preservatives and colour fixatives during cured meat production [7], could increase the nitrosative stress burden of the lung via the formation of reactive nitrogen species [8], causing damage and remodelling of the lung parenchyma [9]. A logical argument is that the lung injury should not only lead to an increased risk of chronic lung disease but also to a worse evolution of disease. However, whether cured meat consumption modifies COPD prognosis has never been tested. The present study aims to assess the association between frequency of cured meat consumption and risk of COPD readmission to hospital in a cohort of COPD patients, in the framework of the Phenotype and Course of COPD (PAC-COPD) study [10]. We hypothesised that subjects with greater intake of cured meat would be at a higher risk of COPD readmission to hospital.

SUBJECTS AND METHODS

Study population

The PAC-COPD cohort, which aims to improve our understanding about the phenotypic heterogeneity of COPD and the extent to which this heterogeneity is related to its clinical course, includes subjects recruited during their first COPD hospital admission at nine university hospitals in Spain between January 2004 and March 2006, and followed up to December 31, 2007. All measures, and the confirmation of COPD diagnosis (post-bronchodilator forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ≤0.70) [11], were obtained during clinical stability at least 3 months after recruitment. Details on recruitment and methods are available elsewhere [10, 12]. The protocol was approved by the ethics committees of all participating hospitals, and written informed consent was obtained from all patients.

Measurements

At baseline, a previously validated 122-item food frequency questionnaire (FFQ) asking for dietary habits in the last 2 yrs was administered by trained interviewers [13, 14]. Cured meat consumption was defined as the total daily consumption (grams per day) of cooked ham, Spanish cured ham, cured and other sausages, and hot dogs, based on five FFQ items.

Baseline sociodemographic characteristics, respiratory symptoms, drug treatment and lifestyle data were obtained using standardised questionnaires. Nutritional status was assessed through body mass index (BMI) and bioimpedance-measured fat-free mass index (FFMI). Post-bronchodilator spirometry (FEV1, FVC and FEV1/FVC), arterial oxygen and carbon dioxide tension (Pa,O2and Pa,CO2, respectively), diffusing capacity of the lung for carbon monoxide, and serum C-reactive protein (CRP) were measured. The Charlson index of comorbidity was obtained by an expert pulmonologist from medical records and personal anamnesis and exploration [15].

All subjects were actively followed until death or until December 31, 2007. Information on COPD readmissions until December 31, 2007 was obtained from the Minimum Basic Dataset Collection (CMBD), a national administrative database. According to the ninth revision of the International Classification of Diseases, COPD exacerbations were defined as any admission with codes 466, 480–6, 490–6 or 518.81 as the main diagnosis. Survival status was obtained for all patients from direct interviews with the patients or their relatives.

Statistical analysis

Sociodemographic, clinical and dietary characteristics were described by mean±sd, median (quartile 1–quartile 3) or n (%), as appropriate. Cured meat intake was treated either as a continuous variable or dichotomised at its median value (22.68 g·day−1), since its biased distribution prevented other categorisations such as quartiles or quintiles. Kaplan–Meier curves of time to first COPD readmission were plotted according to cured meats consumption level, and compared using the log-rank test [16]. Crude and adjusted associations between cured meat intake and time to first COPD readmission were assessed using parametric regression survival–time models, censoring subjects who died before a COPD readmission (n=2) [17]. Age, sex, BMI, FFMI, FEV1, Pa,O2, Pa,CO2, smoking status, physical activity, inhaled corticosteroid treatment, statin treatment, Charlson index of comorbidity, and intakes of energy, fruit, vegetables and fish were tested as potential confounders and included in the final model if they were related to both the exposure and the outcome, or if they modified (>10% change in hazard ratio) the estimates for the remaining variables. Effect modification by smoking status, inhaled corticosteroid treatment, COPD severity and CRP levels was assessed by both stratification of all models and inclusion of interaction terms. Data analysis was conducted using Stata 8.2 (StataCorp, College Station, TX, USA).

RESULTS

From the total PAC-COPD cohort (n=342), 274 patients had available information on diet. No differences regarding sociodemographic characteristics, comorbidities, dyspnoea or lung function parameters were found between patients with and without dietary information, as previously published [13]. Table 1 shows the main characteristics of the 274 COPD patients included in this study, according to daily cured meat intake level. 93% of participants were male with a mean age of 68 yrs. Most subjects had moderate-to-severe COPD (distribution in COPD severity stages: 5% mild, 52% moderate, 37% severe, and 6% very severe). Higher daily cured meat intake was positively related to younger age, current working, current smoking, higher levels of regular physical activity, and lower BMI. Moreover, higher cured meat intake was associated with higher total energy and vegetable intakes, but no relationship was observed with fruits or fish intakes. Median cured meat intake was similar across COPD severity stages (mild: 27 g·day−1, moderate: 24 g·day−1, severe: 21 g·day−1, and very severe: 28 g·day−1; p=0.210).

View this table:
  • View inline
  • View popup
Table 1– Main sociodemographic and clinical characteristics and cured meat intake in 274 chronic obstructive pulmonary disease patients according to cured meat intake level

As shown in table 2, the median follow-up time was 2.6 yrs with a minimum of 250 days and a maximum of 1,337 days. 97 (35%) subjects had at least one COPD hospital readmission. Although 5% of patients died during follow-up, only two (1%) died before any COPD admission, thus contributing to the analysis until death.

View this table:
  • View inline
  • View popup
Table 2– Description of the follow-up of 274 chronic obstructive pulmonary disease (COPD) patients

Kaplan–Meier curves show that the time to the first COPD readmission was longer in the low cured meat intake group (p=0.028) (fig. 1). Table 3 shows that both in the crude and adjusted parametric regression survival–time models, higher cured meat intake was related to higher risk of COPD readmission (adjusted HR 2.02, 95% CI 1.31–3.12; p=0.001). The analysis with cured meats consumption as a continuous exposure yielded a positive increasing association between cured meat intake and risk of COPD readmission (fig. 2).

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Kaplan–Meier survival curves of time to the first chronic obstructive pulmonary disease (COPD) hospitalisation according to cured meat intake. ––––: low cured meat intake; ----: high cured meat intake.

Figure 2–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2–

Hazard ratio (HR) and 95% confidence intervals (CI) of chronic obstructive pulmonary disease readmission according to cured meat intake. HR (––––) and 95% CI (----) were obtained from a parametric regression survival–time model with cured meat intake as a continuous variable, and adjusted for centered age, total caloric intake, and forced expiratory volume in 1 s (FEV1). The baseline HR (risk of readmission when cured meats consumption equals 0 g·day−1) corresponds to the risk of a patient with mean age, mean total caloric intake and mean FEV1.

View this table:
  • View inline
  • View popup
Table 3– Crude and adjusted association between high cured meat intake and chronic obstructive pulmonary disease (COPD) hospital readmission in 274 COPD patients with a median follow-up of 2.6 yrs

After stratification, the estimate of the association between high cured meat consumption and COPD readmission was lower in subjects treated with inhaled corticosteroids than in subjects not using this treatment (HR 1.88, 95% CI 1.16–3.05 versus HR 2.56, 95% CI 0.94–7.02), and lower in subjects with mild and moderate COPD than in severe and very severe COPD patients (HR 1.63, 95% CI 0.85–3.15 versus HR 2.29, 95% CI 1.26–4.16), although interaction terms were not statistically significant (p=0.875 and p=0.577, respectively). Stratification according to smoking status or CRP levels showed no differences in the estimates of the association between cured meats and COPD readmission.

DISCUSSION

We found that higher current cured meat consumption increases the risk of COPD readmission to hospital. These results are coherent with previous studies about cured meats and COPD incidence. Jiang et al. [4] reported in a cross-sectional study of 7,432 subjects that frequent consumption of cured meat was associated with low lung function (FEV1) and with an increased risk of COPD. Later on, studies of two large US cohorts, one of 42,915 males and the other of 71,531 females, showed that cured meat consumption was associated with the risk of newly diagnosed COPD both in males and females [5, 6]. The hypothesis that cured meats consumption may modify the course of COPD had not been tested before, so our findings will benefit from replication in other COPD cohorts.

Experimental evidence about cured meat components supports the biological plausibility of our findings. There is evidence suggesting that nitrites could cause lung damage. In an experimental study, rats that drank water containing sodium nitrite over a 2-yr period developed pulmonary emphysema [18], although the nitrite concentrations in the study were very high and probably not comparable to those achieved in standard human diets. Biochemical evidence shows that nitrites are pro-oxidants and can generate strong oxidising reactive nitrogen species such as peroxynitrite (ONOO-) and others [19, 20]. These reactive nitrogen species are capable of producing lung damage [8], and have been suggested to play a role in the pathogenesis of COPD [9]. Our finding of a weaker effect of high cured meat consumption in subjects treated with inhaled corticosteroids supports the role of nitrites as mediators of the association between cured meats and worse prognosis, since the anti-inflammatory properties of corticosteroids could attenuate the oxidising and pro-inflammatory effects of nitrites. Finally, it has been argued that the largest portion of the nitrite dietary intake could come from vegetables [21], via nitrate to nitrite conversion in the mouth and the stomach [22]. However, it has been shown that high nitrate intake does not cause the expected elevated gastric nitrite concentrations [23, 24], or appreciable changes in serum nitrite concentrations [25], thus enhancing the importance of cured meats as direct sources of nitrites. Another potential mechanism that could explain the deleterious effects of cured meats in COPD course involves salt, which is added during the curing process and could enhance the negative impact of cured meats through an increase of the total body water. It could be especially harmful in COPD patients with concomitant pulmonary hypertension or poor haemodynamic status, where a salt excess could worsen these conditions and ultimately increase the risk of exacerbation.

The median intake of cured meats in the cohort (23 g·day−1) was equivalent to eating one slice of ham every day. It was very similar to the 20 g·day−1 that was found in the 65–75-yr-old strata of a nutritional survey performed during 2002–2003 in the general population of the same geographic area of the PAC-COPD cohort [26], but higher than the consumption reported in the previously mentioned two large US cohorts [5, 6].

There is evidence that a healthy diet could be a beneficial factor in improving and/or preventing multiple chronic diseases, including chronic lung diseases [2, 3]. However, most influential COPD guidelines, such as those produced by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) or the consensus between the American Thoracic Society and the European Respiratory Society, do not include any specific dietary recommendation to COPD patients, beyond the increase of caloric intake for the prevention of weight loss [11, 27]. This study adds new evidence suggesting that in addition to a possible increase in risk of COPD associated with cured meats [4–6] these foods may also increase risk of exacerbations, thus supporting the need to consider giving specific dietary advice to COPD patients.

A limitation of the present study is the potential measurement error in the estimation of cured meat intake due to the use of a food frequency questionnaire. However, any such misclassification is probably nondifferential and therefore would lead to an underestimation of the effects of cured meats. Following this, the presence of subjects who died prior to any COPD readmission could have produced survival bias. However, the small number of deaths before the first hospital readmission (n=2 (1%)) suggests that this bias, if present, is negligible. Finally, information on dietary changes after baseline was unavailable, although, given the current COPD management, it is unlikely that a first COPD admission could promote a reduction in cured meats consumption.

The main strengths of this study are its longitudinal design along with a very accurate characterisation of the study subjects which allowed appropriate control for confounders. Importantly, the latter also included other potentially relevant food groups such as fruits, vegetables and fish. During the follow-up, all hospitalisations were registered thoroughly, and only those with COPD as a main diagnosis were considered in the analysis. Finally, it is noteworthy that all subjects were recruited during their first COPD hospital admission, as we aimed to identify subjects at a similar state of disease evolution, following the evidence-based medicine recommendations for studies on prognosis [28].

In conclusion, high cured meats consumption was associated with an increase in the risk of COPD readmission in COPD patients. Given the economic and health burden of COPD hospitalisations, the assessment of the effectiveness of healthy diet advice should be considered in the future.

Acknowledgments

Author affiliations are as follows. J. de Batlle: Centre for Research in Environmental Epidemiology (CREAL), Hospital del Mar Research Institute (IMIM), CIBER Epidemiología y Salud Pública (CIBERESP), and Dept of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), all Barcelona, Spain. M. Mendez: Centre for Research in Environmental Epidemiology (CREAL), Hospital del Mar Research Institute (IMIM), and CIBER Epidemiología y Salud Pública (CIBERESP), all Barcelona, Spain. I. Romieu: Nutrition and Metabolism – Nutritional Epidemiology Group, International Agency for Research on Cancer, Lyon, France. E. Balcells: Hospital del Mar Research Institute (IMIM), Barcelona and CIBER de Enfermedades Respiratorias (CIBERES), Bunyola, Spain. M. Benet: Centre for Research in Environmental Epidemiology (CREAL), Hospital del Mar Research Institute (IMIM), and CIBER Epidemiología y Salud Pública (CIBERESP), all Barcelona, Spain. D. Donaire-Gonzalez: Centre for Research in Environmental Epidemiology (CREAL), Hospital del Mar Research Institute (IMIM), CIBER Epidemiología y Salud Pública (CIBERESP), and Physical Activity and Sports Sciences Dept, Fundació Blanquerna, Ramon Llull University, all Barcelona, Spain. J.J. Ferrer: CIBER de Enfermedades Respiratorias (CIBERES), Bunyola, and Servei de Pneumologia, Hospital General Universitari Vall d'Hebron, Barcelona, Spain. M. Orozco-Levi: Hospital del Mar Research Institute (IMIM), Barcelona, Dept of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), Barcelona, CIBER de Enfermedades Respiratorias (CIBERES), Bunyola, Spain; and Servicio de Neumología, Fundación Cardiovascular de Colombia, Colombia. J.M Antó: Centre for Research in Environmental Epidemiology (CREAL), Hospital del Mar Research Institute (IMIM), CIBER Epidemiología y Salud Pública (CIBERESP), and Dept of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), all Barcelona, Spain. J. Garcia-Aymerich: Centre for Research in Environmental Epidemiology (CREAL), Hospital del Mar Research Institute (IMIM), CIBER Epidemiología y Salud Pública (CIBERESP), and Dept of Experimental and Health Sciences, Universitat Pompeu Fabra (UPF), all Barcelona, Spain.

The details of the PAC-COPD Study Group are as follows. J.M. Antó (principal investigator), J. Garcia-Aymerich (project coordinator), M. Benet, J. de Batlle, I. Serra, D. Donaire-Gonzalez and S. Guerra: Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain. J. Gea (centre coordinator), E. Balcells, À. Gayete, M. Orozco-Levi and I. Vollmer: Hospital del Mar-IMIM, Barcelona, Spain. J.A. Barberà (centre coordinator), F.P. Gómez, C. Paré, J. Roca, R. Rodriguez-Roisin, À. Agustí, X. Freixa, D.A. Rodriguez, E. Gimeno-Santos and K. Portillo: Hospital Clínic-Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. J. Ferrer (centre coordinator), J. Andreu, E. Pallissa and E. Rodríguez: Hospital General Universitari Vall D'Hebron, Barcelona, Spain. P. Casan (centre coordinator), R. Güell and A. Giménez: Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. E. Monsó (centre coordinator), A. Marín and J. Morera: Hospital Universitari Germans Trias i Pujol, Badalona, Spain. E. Farrero (centre coordinator) and J. Escarrabill: Hospital Universitari de Bellvitge, Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Spain. A. Ferrer (centre coordinator): Hospital de Sabadell, Corporació Parc Taulí, Institut Universitari Parc Taulí (Universitat Autònoma de Barcelona), Sabadell, Spain. J. Sauleda (centre coordinator) and B. Togores: Hospital Universitari Son Dureta, Palma de Mallorca, Spain. J. Bautista Gáldiz (centre coordinator) and L. López: Hospital Universitario de Cruces, UPV, Barakaldo, Spain. J. Belda: Instituto Nacional de Silicosis, Oviedo, Spain.

Footnotes

  • A press release for this article is available from www.erj.ersjournals.com/site/misc/presspack.xhtml

  • Support Statement

    This study was supported by the Spanish Society of Pneumology and Thoracic Surgery (SEPAR 2006/149). J. de Batlle has a pre-doctoral fellowship from the Instituto de Salud Carlos III (FI05/01022), Ministry of Health, Spain. J. Garcia-Aymerich has a researcher contract from the Instituto de Salud Carlos III (CP05/00118), Ministry of Health, Spain. The PAC-COPD Study is funded by grants from: Fondo de Investigación Sanitaria (FIS PI020541), Ministry of Health, Spain; Agència d'Avaluació de Tecnologia i Recerca Mèdiques (AATRM 035/20/02), Catalonia Government; Spanish Society of Pneumology and Thoracic Surgery (SEPAR 2002/137); Catalan Foundation of Pneumology (FUCAP 2003 Beca Marià Ravà); Red RESPIRA (RTIC C03/11); Red RCESP (RTIC C03/09), Fondo de Investigación Sanitaria (PI052486); Fondo de Investigación Sanitaria (PI052302); Fundació La Marató de TV3 (num. 041110); DURSI (2005SGR00392). CIBERESP and CIBERES are funded by the Instituto de Salud Carlos III, Ministry of Health, Spain. The PAC-COPD Study is funded by an unrestricted educational grant from Novartis Farmacèutica, Spain.

  • Statement of Interest

    A statement of interest for this study can be found at www.erj.ersjournals.com/site/misc/statements.xhtml.

  • Received July 8, 2011.
  • Accepted December 22, 2011.
  • ©ERS 2012

REFERENCES

  1. ↵
    1. Mathers CD,
    2. Loncar D
    . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: 2011–2030.
    OpenUrl
  2. ↵
    1. Smit HA,
    2. Grievink L,
    3. Tabak C
    . Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc Nutr Soc 1999; 58: 309–319.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Romieu I,
    2. Trenga C
    . Diet and obstructive lung diseases. Epidemiol Rev 2001; 23: 268–287.
    OpenUrlFREE Full Text
  4. ↵
    1. Jiang R,
    2. Paik DC,
    3. Hankinson JL,
    4. et al
    . Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults. Am J Respir Crit Care Med 2007; 175: 798–804.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Varraso R,
    2. Jiang R,
    3. Barr RG,
    4. et al
    . Prospective study of cured meats consumption and risk of chronic obstructive pulmonary disease in men. Am J Epidemiol 2007; 166: 1438–1445.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Jiang R,
    2. Camargo CA Jr.,
    3. Varraso R,
    4. et al
    . Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women. Am J Clin Nutr 2008; 87: 1002–1008.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Pegg RB,
    2. Shahidi F
    . eds. Nitrite Curing of Meat: the N-nitrosamine Problem and Nitrite Alternatives. Trumbull, Food & Nutrition Press, 2000.
  8. ↵
    1. Ricciardolo FL,
    2. Di Stefano A,
    3. Sabatini F,
    4. et al
    . Reactive nitrogen species in the respiratory tract. Eur J Pharmacol 2006; 533: 240–252.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Kharitonov SA,
    2. Barnes PJ
    . Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Curr Allergy Asthma Rep 2003; 3: 121–129.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Garcia-Aymerich J,
    2. Gómez FP,
    3. Antó JM,
    4. et al
    . Caracterización fenotípica y evolución de la EPOC en el estudio PAC-COPD: diseño y metodología [Phenotypic characterization and course of chronic obstructive pulmonary disease (COPD) in the PAC-COPD Study: design and methods]. Arch Bronconeumol 2009; 45: 4–11.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Celli BR,
    2. MacNee W,
    3. Agusti A,
    4. et al
    . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932–946.
    OpenUrlFREE Full Text
  12. ↵
    1. Balcells E,
    2. Antó JM,
    3. Gea J,
    4. et al
    . Characteristics of patients admitted for the first time for COPD exacerbation. Respir Med 2009; 103: 1293–1302.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. de Batlle J,
    2. Romieu I,
    3. Antó JM,
    4. et al
    . Dietary habits of firstly admitted Spanish COPD patients. Respir Med 2009; 103: 1904–1910.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Martin-Moreno JM,
    2. Boyle P,
    3. Gorgojo L,
    4. et al
    . Development and validation of a food frequency questionnaire in Spain. Int J Epidemiol 1993; 22: 512–519.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Charlson M,
    2. Szatrowski TP,
    3. Peterson J,
    4. et al
    . Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245–1251.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Kaplan EL,
    2. Meier P
    . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.
    OpenUrlCrossRefWeb of Science
  17. ↵
    1. Hosmer DW,
    2. Lemeshow S
    . eds. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, Wiley, 1999.
  18. ↵
    1. Shuval HI,
    2. Gruener N
    . Epidemiological and toxicological aspects of nitrates and nitrites in the environment. Am J Public Health 1972; 62: 1045–1052.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Bian K,
    2. Gao Z,
    3. Weisbrodt N,
    4. et al
    . The nature of heme/iron-induced protein tyrosine nitration. Proc Natl Acad Sci USA 2003; 100: 5712–5717.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Radi R
    . Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 2004; 101: 4003–4008.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Chow CK
    . Consumption of cured meats and risk of chronic obstructive pulmonary disease. Am J Clin Nutr 2008; 88: 1703.
    OpenUrlFREE Full Text
  22. ↵
    1. Lundberg JO,
    2. Weitzberg E,
    3. Cole JA,
    4. et al
    . Nitrate, bacteria and human health. Nat Rev Microbiol 2004; 2: 593–602.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. McKnight GM,
    2. Smith LM,
    3. Drummond RS,
    4. et al
    . Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut 1997; 40: 211–214.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Mowat C,
    2. Carswell A,
    3. Wirz A,
    4. et al
    . Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 1999; 116: 813–822.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Pannala AS,
    2. Mani AR,
    3. Spencer JP,
    4. et al
    . The effect of dietary nitrate on salivary, plasma, and urinary nitrate metabolism in humans. Free Radic Biol Med 2003; 34: 576–584.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Serra Majem L,
    2. Ribas Barba L,
    3. Salvador Castell G,
    4. et al
    . Tendencias del estado nutricional de la población Española: resultados del sistema de monitorización nutricional de Cataluña (1992–2003) [Trends in the nutritional status of the Spanish population: results from the Catalan nutrition monitoring system (1992–2003)]. Rev Esp Salud Publica 2007; 81: 559–570.
    OpenUrlPubMedWeb of Science
  27. ↵
    Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease. 2008. www.goldcopd.com Date last accessed: July 15, 2009.
  28. ↵
    1. Laupacis A,
    2. Wells G,
    3. Richardson WS,
    4. et al
    . Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 1994; 272: 234–237.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 40 Issue 3 Table of Contents
European Respiratory Journal: 40 (3)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cured meat consumption increases risk of readmission in COPD patients
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Cured meat consumption increases risk of readmission in COPD patients
Jordi de Batlle, Michelle Mendez, Isabelle Romieu, Eva Balcells, Marta Benet, David Donaire-Gonzalez, Jaume J. Ferrer, Mauricio Orozco-Levi, Josep M. Antó, Judith Garcia-Aymerich, the PAC-COPD Study Group
European Respiratory Journal Sep 2012, 40 (3) 555-560; DOI: 10.1183/09031936.00116911

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Cured meat consumption increases risk of readmission in COPD patients
Jordi de Batlle, Michelle Mendez, Isabelle Romieu, Eva Balcells, Marta Benet, David Donaire-Gonzalez, Jaume J. Ferrer, Mauricio Orozco-Levi, Josep M. Antó, Judith Garcia-Aymerich, the PAC-COPD Study Group
European Respiratory Journal Sep 2012, 40 (3) 555-560; DOI: 10.1183/09031936.00116911
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • SUBJECTS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Article

  • Lung volumes and survival in chronic lung allograft dysfunction
  • Social consequences of sleep disordered breathing
  • Diagnosing airflow obstruction in COPD
Show more Original Article

COPD

  • Long-acting bronchodilator combination therapy and cardiovascular events in COPD
  • Sensitisation to recombinant A. fumigatus allergens and outcomes in COPD
  • Detection of COPD in the SUMMIT lung cancer screening cohort
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society